INHERET

Lynch syndrome is more common than you may think, and your personal/family medical history is the key to unlocking your risk.
Join us today, along with our friends at AliveAndKickn to raise awareness and understanding about this hereditary condition.

Are you ready to call it quits and ? According to the , using to***co is the #1 Preventable Cause Of Death in the U.S., and 80% of all lung cancers/lung cancer deaths are caused by the choice to smoke.

To***co in any form (ci******es, ci**rs and pipes) can cause cancer, so there is No Safe Form of to***co smoke. Need help and want more information? Visit https://bit.ly/40Vc7lz. INHERET is committed to helping you and your provider take steps toward a healthier tomorrow, today!

February is ! Take the Cancer Prevention Quiz to test your knowledge and learn how to best prevent and reduce your risk of cancer. https://bit.ly/40GZNVT

INHERET believes access to life-saving education, diagnosis, & treatment should be equitable for all – no matter your address, income, ethnicity, age or gender. Show your support and get involved TODAY, February4th!
https://bit.ly/3DFI0oc

Are you aware of Lynch Syndrome and how it can affect you and your loved ones?
, also known as hereditary non-polyposis colorectal cancer ( ), is one of the most common inherited cancer syndromes. Affecting 1 in 279 individuals, states 95% of cases are undiagnosed. Knowing your is the KEY to identifying risks & the next best steps. Start the conversation with your family today!

When was the last time you were screened?
A new study published by the AACR suggests focusing on adherence of cervical cancer screenings AND the continuance of those screenings for women 65 years and older to prevent the onset of Late-Stage Cervical Cancer.

Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California AbstractBackground:. Through adequate screening and follow-up, cervical cancer can be prevented or detected at early-stage (stage I), which is related to excellent survival. Current guidelines recommend discontinuing screening for women ≥65 years with history of normal Pap and/or HPV tests, potent...

With up to 10% of cancers caused by , patients deserve to know their unique risks. They can with INHERET
https://bit.ly/3CShQ1u

INHERET® INHERET provides a comprehensive risk assessment with a personalized approach; empowering individuals to accurately identify their risk for hereditary conditions.

~1 in 8 men will get . It’s the most diagnosed cancer in males. Knowing , signs/symptoms, and risk evaluation is vital for early detection and ! INHERET provides the tools needed.

We are pleased to announce Jessica Wood as the new Senior Director of Health System Sales. As a Six Sigma LEAN Certified medical sales professional, she is passionate about cancer prevention and personalized medicine. She has focused her career on partnering with providers and companies to stratify cancer risk and elevate outcomes for patients and their families. A mom of two children and a “Previvor” with a CHEK2 mutation, Jessica has made it her life mission to increase access and equity in the cancer care industry and INHERET positions her perfectly to do just that.

Less than three weeks away - !! Kelly Hall, CEO of INHERET, Inc. will be featured as a showcase speaker at Precision Medicine World Conference - PMWC LLC
on Day 1, June 28.

Join us in raising awareness of the importance of knowing cancer history on BOTH sides of your family, as well as improving access to prompt and counselling for those living with a diagnosis of . matters!

We join the American Academy of Dermatology by wearing orange and to for and .

Did you know there are genes associated with an increased risk of developing skin cancer? INHERET screens for hereditary as well as other .

Per our friends at (ICARE):

Pathogenic variants in 𝘊𝘋𝘒𝘕2𝘈 have been estimated to account for 35-40% of all familial melanomas. Other genes associated with increased melanoma risk include 𝘉𝘈𝘗1, 𝘗𝘖𝘛1, and 𝘊𝘋𝘒4. Additionally, basal cell nevus syndrome or Gorlin Syndrome, caused by pathogenic variants in 𝘗𝘛𝘊𝘏1, is associated with an increased risk of basal cell carcinoma.

Learn more of the of via National Cancer Institute 👇

https://lnkd.in/gphVtjf